Identification of patent foramen ovale permitting paradoxic embolism  by Hausmann, Dirk et al.
1030 JACC VoL 26, No. 4 
October 1995:1030-8 
Identification of Patent Foramen Ovale Permitting 
Paradoxic Embolism 
DIRK HAUSMANN,  MD, ANDREAS MI JGGE,  MD, FACC, WERNER G. DANIEL,  MD, FACC 
Hannover, Germany 
Objectives. We sought to analyze th  morphologic and func- 
tional characteristics of the patent foramen ovale in patients with 
different clinical likelihoods f r paradoxic embolism. 
Background. The incidence of patent foramen ovale is increased 
in patients with otherwise unexplained arterial ischemic events. 
Because signs of venous thrombosis are absent in most patients, 
the diagnosis of paradoxie embolism is often questioned, even 
when patent foramen ovale is the only potential explanation for 
the ischemic event. 
Methods. Seventy-eight patients with a patent foramen ovale 
detected by contrast ransesophageai echocardiography were 
studied: 21 patients with an otherwise unexplained arterial isch- 
emic event and clinical evidence implying paradoxic embolism 
(group I), 30 patients with an unexplained ischemic event but o 
clinical evidence for paradoxic embolism (group II) and 27 
patients without anischemic event (group III). 
Results. During transesophageal contrast echocardiography, 
patients in group I had more severe right to left shunting (mean -+ 
SD 52 _+ 16% of the left atrial area filled with contrast medium) 
and a wider opening of the patent foramen ovale (7.1 -+ 3.6-mm 
separation between the septum primum and the septum secun- 
dum) than did patients in group II (35 -+ 15% and 4.4 -+ 3.2 ram, 
respectively, p < 0.001) or group III (23 + 12% and 3.0 -+ 2.0 ram, 
respectively, p < 0.001). The incidence of atrial septal aneurysm 
was similar in the three groups. Severe contrast shunting (>50% 
of theleft atrial area filled with contrast medium) and wide 
opening of the patent foramen ovale (_>5-ram separation) revealed 
a high sensitivity (71% and 86%, respectively) and high specificity 
(86% and 96%, respectively) for identification of group I patients. 
Conclusions. Right to left contrast shunting is more severe and 
opening of the patent foramen ovale is larger in patients with 
ischemic arterial events considered to be due to paradoxic embo- 
lism. In patients with a p tent foramen ovale s the only potential 
cause for ischemic events and no signs of venous thrombosis, 
morphologic and functional variables as essed by transesophage- 
al echocardiography may be helpful in estimating the likelihood of
paradoxic embolism. 
(J Am Coil Cardiol 1995;26:1030-8) 
A patent foramen ovale is the window to the systemic circula- 
tion in the majority of patients with paradoxic arterial embo- 
lism (1-3). It has been suggested (4-8) that paradoxic embo- 
lism by way of a patent foramen ovale may occur in a 
significant number of patients with otherwise unexplained 
arterial embolism. However, in individual patients the clinical 
diagnosis of paradoxic embolism often remains uncertain, even 
when a patent foramen ovale is the only potential source of 
ischemic events. 
Paradoxic embolism can be considered proved (9) only 
when thrombotic material is found lodged in the interatrial 
septum ("impending paradoxic embolism"), a rare finding at 
autopsy (10) or during life (ll). Paradoxic embolism can be 
presumed (9) when signs of venous thrombi are present; 
however, such signs are absent in most patients with patent 
foramen ovale and otherwise unexplained ischemic events 
(12,13). 
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It would be clinically useful to be able to characterize patent 
foramen ovale into those conditions more likely or less likely to 
allow paradoxic embolism. Previous tudies (5-8) have only 
determined the absence or presence of patent foramen ovale in 
patients with ischemic events. In the present study, morpho- 
logic and functional characteristics of patent foramen ovale 
analyzed by transthoracic and transesophageal echocardiogra- 
phy are compared in patients with different clinical ikelihoods 
of paradoxic embolism. 
Methods 
The study was performed in 78 consecutive patients be- 
tween July 1987 and May 1992 at Hannover Medical School; 
all patients had a patent foramen ovale detected by transesoph- 
ageal contrast echocardiography. According to their history of 
arterial ischemic events, the patients were classified into three 
groups: patients with presumed or proved paradoxic embolism 
(group I), patients with otherwise unexplained arterial isch- 
emic events but no additional findings suggesting paradoxic 
embolism (group II) and control patients without a history of 
arterial ischemic events (group III). 
Patients (Table 1). Group L In 21 patients (group I), 
arterial ischemic events had occurred but no source of the 
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Table 1. Baseline Characteristics of 78 Patients With a Patent 
Foramen Ovale 
Group II: Group IlL 
Group 1: Unexplained No 
Paradoxie [schemic Ischemic 
Embolism Events Events 
(n = 21) (n -- 30) (n = 27) 
Men/women 13/8 18/12 17/10 
Age (yr) 52 ± 11 42 ± 14 52_+ 14 
Type of arterial ischemic event 
Nonhemorrhagic stroke 13 19 - -  
Transient ischemic attack 3 6 - -  
Peripheral arterial embolism 5 5 - -  
Data are expressed as number of patients or mean value _+ SD. 
events (other than patent foramen ovale) was identified. All 
patients in this group had additional signs indicating that 
paradoxic embolism may have been the pathomechanism of 
the event. Paradoxic embolism was presumed in the current 
presence of thrombotic material lodged in the interatrial 
septum, deep venous thrombosis, pulmonary embolism or the 
presence before an ischemic event of an unequivocal Valsalva 
maneuver or severe chronic venous insufficiency with rom- 
bophlebitis. 
Diagnosis of suspected cerebral artery embolism was based 
on unequivocal acute focal neurologic deficits without other 
explanation after careful neurologic examination. All patients 
with stroke or transient ischemic attacks were evaluated by 
cerebral computed tomography or magnetic resonance imag- 
ing, or both. Nonhemorrhagic infarct zones were demonstrated 
in all patients with stroke and in two of three patients with 
transient ischemic attacks. No patient with cerebral ischemia 
had >30% carotid artery obstruction by Doppler ultrasound 
examination. Peripheral arterial embolism was confirmed by 
angiography in all five patients with this finding; furthermore, 
the embolus was confirmed by subsequent opera ion in all 
patients, History, cardiovascular physical examination as well 
as transthoracic and transesophageal echocardiography dem- 
onstrated no abnormality (other than patent foramen ovale) 
explaining the ischemic event. 
Group II. In 30 patients with otherwise unexplained arte- 
rial events (group II), a patent foramen ovale was diagnosed by 
transesophageal contrast echocardiography but no additional 
findings suggested hepresence of paradoxic embolism. Again, 
all patients with stroke or transient ischemic attacks were 
evaluated by cerebral computed tomography or magnetic 
resonance imaging, or both. Nonhemorrhagic infarct zones 
were demonstrated in all patients with stroke and in three of 
six patients with transient ischemic attacks. None of these 
patients had >30% carotid artery obstruction by Doppler 
ultrasound examination. Peripheral arterial embolism was 
diagnosed by angiography in all patients and confirmed in all 
four surgically treated patients. As in group I, the history, 
cardiovascular physical examination and transthoracic and 
transesophageal echocardiography revealed no abnormality 
(other than patent foramen ovale) explaining the ischemic 
event. In 27 of the 30 patients, deep venous thrombosis was 
excluded by angiography or Doppler ultrasound examination, 
or both; in 3 patients, no clinical signs or risk factors for deep 
venous thrombosis were present. No patient had clinical signs 
of pulmonary embolism before or during the ischemic event. 
Group IlL Twenty-seven patients (group III) had no his- 
tory of arterial ischemic events, and patent foramen ovale was 
an incidental finding during transesophageal chocardiogra- 
phy. Transthoracic and transesophageal echocardiography 
were performed to exclude ndocarditis (n = 7) or congenital 
heart disease (n = 6), and no abnormal findings were detected; 
these patients were considered normal control subjects. In the 
remaining 14 patients, aortic disease (n = 10) or minimal 
valvular disease (n = 4) was present. None of these abnormal- 
ities was considered to have a significant impact on left heart 
hemodynamics, and contrast studies were performed only to 
establish a control group. 
Echocardiography. Transthoracic echocardiography was 
performed by standard techniques with the use of 2.5- or 
3.5-MHz phased array transducer systems (Hewlett-Packard, 
Acuson Computed Sonography). For optimal visualization of 
the interatrial septum, all imaging was performed from the 
parasternal, apical and subxiphoid windows. Transesophageal 
echocardiography was performed within 24 h of the trans- 
thoracic examination with a monoplane (48 patients) or bi- 
plane (30 patients) 5.0-MHz phased array transducer. Patients 
had fasted ~4 h and received local pharyngeal nesthetic 
agents as the only premedication. Written informed consent 
was obtained from all patients and investigations were carried 
out without complications. The transesophageal xaminations 
were performed exclusively for diagnostic reasons and were 
usually completed within 15 min. Potential cardiac sources of 
arterial embolism other than abnormalities of the atrial septum 
were excluded by transesophageal echocardiography (e.g., 
intracardiac thrombi, cardiomyopathies, spontaneous left 
atrial echo contrast, mitral valve stenosis orprolapse, mitral or 
aortic valve vegetations or aortic atheromas). 
During transthoracic and transesophageal chocardiogra- 
phy, the interatrial septum was carefully examined. An optimal 
view of the interatrial septum and the left atrium was selected 
and contrast echocardiography was performed by injecting 10 
ml of agitated oxypolygelatine solution (Gelifundol, Biotest 
Pharma Inc.) rapidly through an antecubital vein. The solution 
was prepared by shaking the vial, then extruding all macro- 
scopic air. Three contrast injections were performed uring 
transthoracic and again during transesophageal echocardiog- 
raphy. The Valsalva maneuver was started at the time of 
contrast injection. When contrast bubbles appeared in the 
right atrium, the patient was asked to quickly stop straining. A 
right to left shunt was diagnosed when ->5 bubbles appeared in
the left atrium in the region of the fossa ovalis during the first 
three cardiac ycles after release from the Valsalva maneuver. 
Three predefined echocardiographic variables were ana- 
lyzed. 1) Severity of right to left shunting: The video frame with 
the maximal contrast opacification of the left atrium was 
selected (Fig. 1). The total area of the left atrium and the area 
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Figure I. Transesophageal echocardiograms (horizontal 
plane) from patients with different degrees of right to left 
contrast shunting through a patent foramen ovale, a, A small 
amount of contrast material appears in the left atrium (LA) 
in the region of the foramen ovale after release from the 
Valsalva maneuver, b, Theleft atrium isfilled with contrast 
bubbles in another patient with severe right to left shunting. 
RA - right atrium. 
filled with contrast bubbles were traced manually and calcu- 
lated by using planimetry (Fig. 2). The percent of the left atrial 
area filled with contrast medium was calculated and the 
average of the three contrast injections was determined. 2) 
Opening of the patent foramen ovale: The region of contact 
between the septum primum and the septum secundum was 
identified. In the longitudinal plane, separation of the septum 
primum and secundum could be observed in nearly all cases 
(Fig. 3). In the horizontal p ane, the septum primum separates 
from the rest of the interatria[ septum, but a clear, channel 
type of communication between both atria cannot be observed 
in all patients. The maximal degree of patent foramen ovale 
opening was measured as the distance between the leading 
edge of the septum primum and secundum after release from 
the Valsalva maneuver (Fig. 4). This variable could be mea- 
sured in the horizontal plane in 48 patients and in the 
longitudinal plane in 3{) (in 51 during M-mode and in 27 during 
two-dimensional imaging). 3) Atrial septal neurysm: Criteria 
for diagnosis of atrial septal aneurysm were used according to 
the method of Hanley et al. (14) (Fig. 5). In the transthoracic 
echocardiographic studies, only the presence of a shunt and of 
an atrial septal aneurysm was analyzed. 
All echocardiograms were evaluated by two independent 
observers: The operator of the transesophageal examination 
evaluated the transthoracic and transesopbageal studies imme- 
diately after the procedure, and a second physician evaluated 
the videotape recordings without knowledge of the first eval- 
uation. In cases of disagreement, both observers reevaluated 
the studies together and a consensus was reached. 
Follow-up. Further treatment after the ischemic event in 
the 51 study patients with such an event (groups I and II) 
included surgical closure of the patent foramen ovale (n = 3) 
and administration of sodium warfarin (n = 31) or aspirin (n = 
17). Follow-up data were obtained by questionnaires concern- 
ing the occurrence of new events (transient ischemic attacks, 
stroke, peripheral arterial embolism); in addition, family phy- 
sicians were questioned by telephone. Follow-up data were 
available in 44 (86%) of the 51 patients; the observation period 
was 59 _+ 12 months (range 37 to 95), 
Statistical analysis. The data are expressed as mean 
value + 1 SD. Patients in groups I, II and Ill were compared 
by analysis of variance followed by multiple rank tests of 
Scheff& A probability value <0.05 wasconsidered significant. 
By comparing patients of groups I and III, sensitivity, specific- 
ity and predictive values of echocardiographic variables to 
identify' patent foramen ovale allowing paradoxic embolism 
were calculated. 
Resul ts  
Patient characteristics. Baseline characteristics of patients 
in groups I to IIl are listed in Table l. In group I, paradoxic 
embolism was considered proved or presumed, because addi- 
tional findings provided evidence for this pathomeehanism 
(Table 2): In two patients, paradoxic embolism was regarded as 
proved because thrombotic material lodged in the interatrial 
septum was detected; in both patients, a long overriding 
thrombus with mobile parts in the right and left atrium was 
Figure 2. Transesophageal echocardiograms (horizontal 
plane) from a patient with right to left contrast shunting 
through a patent foramen ovale, a, Contrast material appears 
in the left atrium (LA) in the region of the foramen ovale after 
release from the Valsalva maneuver, b, Thearea of the left 
atrium filled with contrast material is traced to determine the 
severity of right to left shunting. RA = right atrium. 
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Figure 3. Transesophageal echocardiograms (longitudinal 
plane) from a patient with a patent foramen ovale, a, 
During normal respiration the foramen ovale is closed, b, 
After contrast injection and release from the Valsalva 
maneuver, the foramen ovale is wide open. Contrast 
bubbles (arrow) cross the atrial septum during end-systole. 
c, Contrast bubbles enter the left atrium, d, The left atrium 
is filled with contrast bubbles, and the foramen ovale is 
closed. AO = aorta; other abbreviations as in Figure 1. 
seen (Fig. 6). Both patients had deep venous thrombosis 
whereas pulmonary embolism was clinically evident in only one 
patient. In 12 other patients, deep venous thrombosis, pulmo- 
nary embolism, or both, was present. The ischemic event had 
occurred after an unequivocal Valsalva maneuver in two 
patients. Severe chronic venous insufficiency with thrombo- 
phlebitis was present in five patients (Table 2). 
Echocardiographic findings. During transesophageal echo- 
cardiographic maging, the degree of right to left shunting (Fig. 
1 and 2) and of opening of the patent foramen ovale (Fig. 3 
and 4) as well as the presence of an atrial septal aneurysm (Fig. 
5) were evaluated. The contrast shunt was more severe in 
group I (52 _+ 16% of the left atrial area filled with contrast 
bubbles) than in group II (35 + 15%, p < 0.001) or group III 
Figure 4. Same patient as in Figure 3. M-mode recording during 
transesophageal echocardiography (horizontal plane) in apatient with 
a patent foramen ovale. The recording shows the atrial septum in the 
region of the patent foramen ovale (top). After release from the 
Valsalva maneuver, the septum primum and secundum show a maxi- 
mal separation of 14 mm (arrows) during end-systole (bottom). 
Figure 5. Transesophageal echocardiograms (horizontal plane) from a 
patient with an atrial septal aneurysm, a, The interatrial septum is bulging 
into the fight atrium (RA). b and e, Theatrial septum is shifting from the 
fight to the left atrium (LA). d, Bulging of the interatrial septum to the left 
atrium at end-systole. Arrows indicate the measurement of the base width 
and excursion f the atrial septal aneurysm. 
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Table 2. Patients With Presumed Paradoxic Embolism (group I) 
TIrE TEE  
Atrial Shunt PFO Atrial Evidence for 
Pt Age (yr)/ CV Risk Ischemic Septal ->50% Opening Septal Paradoxic 
No. Gender Factor Event Shunt Aneurysm of LA ->5 mm Aneurysm Embolism 
1 45/M - -  T IA  + - + + - PE, DVT 
2 54/F - -  Stroke + - + + - DVT 
3 43/F NIC T IA  . . . .  DVT  
4 58/F - -  Peripheral EMB - - - PE  
5 55/M - -  Stroke t + + + + CVI 
6 59/F HTN Stroke - - - + + CVI 
7 47/M - -  Peripheral EMB . . . .  CVI, VAL 
8 39/M - -  Stroke + - + + - DVT 
9 48/M NC Stroke + - + + - VAL 
10 38/M - -  Stroke + + + - VAL  
11 50/M - -  Peripheral EMB - - + + - PE, DVT 
12 49/M DM Peripheral EMB + - + + - THR,  DVT 
13 37/M - -  Stroke - + + + PE, CVI 
14 28/F NIC, OC Stroke + * + + PE, DVT 
15 38/M N1C Peripheral EMB - - + - CVI 
16 54/M - -  T IA  + + + - CVI 
17 67/F - -  Stroke + - + + - THR,  PE, DVT 
18 66/F - -  Stroke + - - + PE, CVI 
19 35/M - -  Stroke - + t + DVT 
20 47/M - -  Stroke + + + - PE, DVT 
21 39/F - -  Stroke + + + - DVT 
CV cardiovascular; CVI chronic venous insufficiency with thrombophlebit is: DM - diabetes mellitus; DVT - deep venous thrombosis; EMB = embolism; 
F - female; HTN - hypertension: LA = left atrium; M male; NIC - nicotine use: OC = oral contraceptive use; PE = pulmonary, embolism; PFO = patent  foramen 
ovale; Pt = patient; TEE  - transesophageal  echocardiography; T IA  = transient ischemie attack; THR = thrombus lodged in the interatrial septum; T I 'E  = 
transthoracic echocardiography; VAL  Valsalva maneuver before ischemic event. 
(23 _+ 12%, p < 0.001) (Fig. 7). The opening of the patent 
foramen ovale was larger in group I (7.1 + 3.6-mm separa- 
tion between the septum primum and secundum) than in 
group II (4.4 ± 3.2 ram, p < 0.001) or group IlI (3.0 ± 
2.0 ram, p < 0.001) (Fig. 8). On the basis of these findings, 
opacification ->50% of the left atrium was considered a sign 
for severe contrast shunting and separation ->5 mm a 
marker for wide opening of the patent foramen ovale. The 
frequency of atrial septal aneurysm detected by transesoph- 
ageal echocardiography was not significantly different in the 
three groups. Initial discrepancies between the two indepen- 
dent observers occurred in five patients (6.4%) for detection 
of a severe right to left shunt, in six (7.7%) for wide opening 
of the patent foramen ovale and in two (2.6%) for atrial 
septal aneurysm. 
During transthoracic imaging, a shunt was found more 
frequently in group I patients than in group II or III patients; 
atrial septal aneurysms were equally frequent in all groups 
(Fig. 9). Among the 22 patients with severe contrast shunting 
by transesophageal echocardiography (15 in group I, 6 in group 
II, 1 in group III), 19 (86%) could also be identified by 
transthoracic echocardiography. Discrepancies between the 
two observers occurred for transthoracic echocardiographic 
detection of a right to left shunt in five patients (6.4%) and for 
detection of atrial septal aneu~sm in two (2.6%). 
Accuracy of echocardiographic variables. To identify the 
characteristics of patent foramen ovale that potentially allow 
paradoxic embolism, the echocardiographic findings in 
groups I and III were compared. Sensitivity, specificity and 
predictive values of the echocardiographic findings are 
listed in Table 3. Presence of severe contrast shunt and wide 
opening of the patent foramen ovale assessed by transesoph- 
ageal echocardiographic imaging showed a good sensitivity 
and excellent specificity for identification of a patent fora- 
men ovale that had probably allowed paradoxic embolism. A
severe shunt observed by transthoracic echocardiography 
was less ensitive but had good specificity and predictive 
values. Of the 30 group II patients, 5 (17%) had wide 
opening of the patent foramen ovale, 1 patient (3%) had 
severe contrast shunting and 5 patients (17%) showed both 
signs. In contrast, 19 patients (63%) had a patent foramen 
ovale that was unlikely to allow paradoxic embolism accord- 
ing to these criteria. 
Follow-up. Follow-up data could be obtained in 44 (86%) 
of the 51 patients with ischemic events and a patent foramen 
ovale. During an observation period of 59 _ 12 months, 
ischemic events occurred in three patients (7%) (two transient 
ischemic attacks, one stroke) (Table 4). Group II patients 
with ischemic events during follow-up showed severe contrast 
shunting (one patient) or both severe contrast shunting and 
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Figure 6. Thrombus lodged in a patent foramen ovalein a patient with 
deep venous thrombosis, pulmonary embolism and stroke. Trans- 
esophageal echocardiograms in the longitudinal plane (a and b) and 
the horizontal plane (c and d). a, The thrombus (arrows) has mobile 
ends in the right (RA) and left (LA) atria, b, The thrombus (arrow) is 
shown in the left atrium, c, This frame provides an oblique view of the 
thrombus lodged in the foramen ovale (arrow). d, The entire length of 
the thrombus (arrow) in the left atrium is seen in the horizontal plane. 
AO = aorta; LV = left ventricle. 
wide opening of the patent foramen ovale (one patient) during 
the initial echocardiographic study. 
Discuss ion  
Diagnosis of patent foramen ovale. At autopsy, a patent 
foramen ovale is found in 19% to 36% of subjects (15). When 
transthoracic contrast echocardiography is used, a right to left 
shunt after the Valsalva maneuver is found in 10% to 24% of 
normal persons (4,5,16,17), whereas transesophageal contrast 
echocardiography detects hunting through a patent foramen 
Figure 7. Severity of right to left shunting assessed by transesophagcal 
echocardiography in patients with a patent foramen ovule. ***p < 
0.001; *p < 0.05. Group I = patients with presumed paradoxic 
embolism; Group II = patients with unexplained ischemic events but 
no clinical evidence forparadoxic embolism; Group llI = patients with 
no ischemic events; LA = left atrium. 
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Figure 8. Opening of the patent foramen ovale (PFO) assessed by 
transesophageal echocardiography. ***p < 0.001; n.s. = not signifi- 
cant. Groups as defined  Figure 7. 
ovale in 22% to 39% (8,18,19). Several studies using trans- 
thoracic or transesophageal contrast echocardiography ave 
shown that the incidence of a patent foramen ovule is in- 
creased in young (4-8) and also older (6,7) adults with 
otherwise unexplained arterial ischemic events. From these 
studies it was concluded that a patent foramen ovale may play 
a role in the pathomechanism of ischemic events in a signifi- 
cant number of patients. 
Diagnosis of paradoxic embolism. Despite the obvious 
association with otherwise unexplained ischemic events, detec- 
tion of a patent foramen ovale does not prove that paradoxic 
embolism has occurred (12,13). The clinical diagnosis of 
paradoxic embolism requires additional findings: Paradoxic 
Figure 9. Incidence of right to left contrast shunting and atrial septal 
aneurysm (ASA) as assessed by transthoracic echocardiography in 
patients with a patent foramen ovale. The numbers above the bars 
indicate the number of patients with these conditions in each group. 
***p < 0.00]; n.s. = not significant. Solid bars = group I; hatched 
bars = group II; open bars = group III (control). Groups as defined 
in Figure 7. 
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Table 3. Accuracy of Echocardiographic Variables in Identifying a 
Patent Foramen Ovale Allowing Paradoxic Embolism 
Sensitivity Specificity 
Positive Negative 
Predictive Predictive 
Value Value 
TEE 
Severe shunt 71% 96% 94% 79% 
Wide PFO opening 86qi 89% 86% 89% 
Atrial septal neurysm 29% 93% 75% 63% 
TIE 
Shunt 62% 96% 93% 76';:~ 
Atrial septal aneurysm 10% 100% 100% 59% 
PFO = patent foramen ovale; other abbreviations as in Table 2. 
Table 4. Follow-Up Data in 44 Patients With an Ischemic Event 
and a Patent Foramen Ovale 
Patients Follow-Up Period Ischemic Events 
Treatment (no.) (too) During Follow-Up 
Group I (n : 18) 
Surgical closure 3 40-89 No events 
Sodium warfarin 13 37-87 No events 
Aspirin 2 45-82 1 TIA 
Group II (n = 26) 
Sodium warfarin 11 42-95 1 TIA 
Aspirin 15 41-85 1 stroke 
Groups as defined in Table 1. TIA = transient ischemic attack. 
embolism is considered proved (9) only when thrombotic 
material is found lodged in a patent foramen ovale. It can be 
considered presumed when thrombi in the venous circulation 
are present in patients with a patent foramen ovale and 
unexplained ischemic events (9). 
The diagnosis of paradoxic embolism remains even mor  
questionable when no signs of venous thrombi are found. This 
is the case in most patients with a patent foramen ovale as the 
only potential cause of an ischemic event (12,13). Although 
Ranoux et al. (12) detected a patent foramen ovale in 47% of 
patients with an ischemic event, Valsalva-provoking activities 
preceding the event and other features uggesting paradoxic 
embolism were not more frequent in patients with than in 
patients without patent foramen ovale. In the study of Gautier 
et al. (13), only 3 of 23 patients with a patent foramen ovale 
and unexplained stroke demonstrated deep venous thrombosis 
at venography. The lack of associated signs for paradoxic 
embolism may indicate that paradoxic embolism has not 
occurred, or it may be due to under recognition of venous 
thrombi. In -50% of patients, deep venous thrombosis re- 
mains clinically silent a d even in patients with proved pulmo- 
nary embolism, deep venous thrombosis may remain undetec- 
ted by angiography (20). Furthermore, in clinical practice a 
patent foramen ovale is frequently diagnosed weeks or months 
after the ischemic event has occurred and venous thrombi may 
already have disappeared. The diagnostic dilemma in patients 
with patent foramen ovale who have otherwise unexplained 
ischemic events and no other evidence for paradoxic embolism 
requires the identification of patent foramen ovale with and 
without increased embolic potential. 
Opening of the patent foramen ovale. In the present study, 
severe contrast shunting and wide opening of the patent 
foramen ovale could be identified as reliable indicators of 
patent foramen ovale that had allowed paradoxic embolism. 
Our findings suggest that paradoxic embolism seems to be 
unlikely in patients with arterial ischemic events but only a 
small opening of the patent foramen ovale. However, it cannot 
be ruled out that a small patent foramen ovale may allow 
paradoxic embolism of small thrombi, causing clinically silent 
ischemic events. Despite the findings of the present study, it is 
important to state that the method of contrast echocardiogra- 
phy has not been validated as a means of quantifying the 
volume of right to left intracardiac shunting or the size of a 
patent foramen ovale. 
The size of the patent foramen ovale as measured uring 
autopsy ranges between 1and 19 mm (15). Bridges et al. (21) 
determined the stretched patent foramen ovale diameter and 
compared it to the predicted patent foramen ovale size based 
on age-adjusted autopsy data. In 67% of their patients, the 
actual patent foramen ovale size was ->2 SD larger than the 
pr dicted mean size for the corresponding age group. Webster 
et al. (4) detected a right to left shunt by contrast transthoracic 
echocardiography in 50% of stroke patients and in 15% of 
control subjects; when stroke patients and control subjects 
were compared, a difference was found between groups with 
severe (20% vs. 0%) and moderate (20% vs. 5%) shunts but 
not between groups with small shunts (10% vs. 10%). Van 
Camp et al. (18) found no difference between the prevalence of 
patent foramen ovale in 29 patients with unexplained stroke 
and 28 control subjects; a significant difference was found when 
only the early and massive contrast shunts were considered. 
When the complete spectrum of patent foramen ovale sizes 
is considered, transesophageal contrast eehocardiography is 
more sensitive than the transthoracic approach for detection of 
patent foramen ovale. However, the two methods appear to be 
comparable for detecting larger, clinically important patent 
foramen ovale. This observation may explain why in patients 
with paradoxic embolism, the patent foramen ovale is often 
already detectable by transthoracic contrast echocardiography 
(4-6). Among the 15 patients with presumed paradoxic em- 
bolism and severe contrast shunt by transesophageal chocar- 
diography in our study, 13 (87%) had a shunt that could be 
detected also by transthoracic contrast echocardiography. On 
the basis of these observations the use of transthoracic contrast 
echocardiography appears to be sufficient for detection of 
clinically relevant patent foramen ovale. However, transesoph- 
ageal echoeardiography may still be indicated because other 
sources of cardiac embolism can better be detected by this 
approach (22,23). Differentiation between transseptal and 
transpulmonary contrast passage (24) and improved visualiza- 
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tion of overriding thrombi (11) also suggest the utility of 
transesophageal chocardiographic imaging. 
Atrial septal aneurysm. Because of the increased preva- 
lence of atrial septal aneurysms in patients with arterial 
ischemic events, these aneurysms are considered cardiac ab- 
normalities with embolic potential (25,26). This potential may 
be due to associated interatrial shunting allowing paradoxic 
embolism, atrial arrhythmias or thrombus formation at the 
aneurysm. In the present study, the incidence of atrial septal 
aneurysm was similar in patients with presumed paradoxic 
embolism, in those with unexplained embolism andin patients 
without embolic events. Our results do not contradict obser- 
vations on the embolic potential of this abnormality; rather, 
they indicate that the presence of an atrial septal aneurysm in 
patients with patent foramen ovale does not influence the risk 
of paradoxic embolism. 
Follow-up, Clinical follow-up data could be obtained in 44 
(86%) of the patients with ischemic events and a patent foramen 
ovale. Only three patients (7%) had ischemic events during the 
observation period. The low incidence of ischemic events may be 
explained by the short follow-up period (59 _+ 12 months); in 
addition, the treatment (surgical closure in 3 patients and admin- 
istration of sodium warfarin in 15and aspirin in 17) may have 
prevented further events. Because of the low incidence of events, 
the prognostic significance of echocardiographic variables to 
detected patent foramen that allow paradoxic embolism cannot 
be determined from our study. 
Limitations of the study. Our study has several limitations. 
1) Identifying the plane of separation between the septum 
primum and the septum secundum may cause problems, 
particularly during respiratory maneuvers. Our experience is
that the plane of the separation often shows a typical pattern 
and can already be identified uring normal respiration. This 
plane has to be adjusted meticulously before respiratory 
maneuvers are performed. If applicable, the longitudinal trans- 
esophageal echocardiographic plane should be used for this 
purpose. When the imaging plane is kept unchanged uring 
the Valsalva maneuver, the region of the patent foramen 
ovale returns to the imaging plane after release from the 
maneuver (time of maximal right to left shunt). Measure- 
ment of the separation is then best performed in the 
M-mode display. 2) Group I patients were heterogeneous 
with regard to the likelihood of paradoxic embolism. In 
some patients, paradoxic embolism was proved by a throm- 
bus overriding the atrial septum. These patients were 
grouped with patients who had severe chronic venous 
insutticiency and thrombophlebitis. Although the latter may 
be considered only a risk factor for development of deep 
venous thrombosis, paradoxic embolism seemed to be likely 
in these patients. 3) Because group III patients had a clinical 
indication for a transesophageal echocardiographic study, 
referral bias may have been present in this group. 4) 
Determination of shunt severity by calculating the l ft atrial 
area filled by contrast medium may be difficult. The bubbles 
may not be in the imaging plane, or small numbers of 
bubbles may spread out and fill large parts of the atrium. 
Therefore, the shunt severity was averaged from three contrast 
injections and the size of the patent foramen ovale was also 
described by the anatomic separation between the septum pri- 
mum and the septum secundum. The prognostic significance of 
these variables remains to be determined in further studies. 
Clinical implications. In patients with a patent foramen 
ovale as the only potential cause for arterial ischemic events, 
morphologic and functional features of the patent foramen ovale 
should be evaluated by transesophageal contrast echocardi- 
ography, particularly when other indicators for paradoxic 
embolism are missing. Severe right to left atrial shunting or 
wide opening of the patent foramen ovale, or both, is clearly 
associated with clinical signs suggesting paradoxic embolism 
in those patients who have experienced otherwise un x- 
plained events. In patients with a small patent foramen 
ovale, the likelihood that paradoxic embolism has occurred 
seems to be low. 
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